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The Editorial on the Research Topic
Cognitive Event-Related Potentials in Psychopathology: New Experimental and Clinical
Perspectives
A common feature of many psychopathological states (going from anxiety, depression to
schizophrenia, or addictive states) is to be associated with large-scale cognitive impairments, which
have a clear impact on the onset and maintenance of clinical symptoms (Menon, 2011). Therefore,
studies have shown that the training and rehabilitation of cognitive skills lead to positive effects on
patients’ quality of life, centrally by decreasing the severity of these clinical symptoms (e.g., Pilling
et al., 2002). However, beyond patent cognitive impairments, some minor cognitive restrictions
can also be present and, even if not observable at the behavioral level, may induce a state of
“vulnerability” that can, in some circumstances, facilitate the persistence of the psychopathology
(Levit Binnun and Golland, 2012). In alcohol-related disorders for example, it is well-known
that, despite a well-structured detoxification treatment encompassing psychiatric, psychological
and pharmacological therapies, 50–90% of patients will relapse or restart consuming alcohol in
the year following detoxification (Boothby and Doering, 2005). In this view, it appears urgent to
find biological markers which can go beyond classical behavioral assessment to detect even minor
cognitive alterations. These new tools would help clinicians to identify which patients are more
at-risk to develop or extend psychopathologies, and would thus significantly improve treatment
through best suited medication as well as specialized and individualized cognitive rehabilitation
programs (Campanella, 2016).
In this topic, our aim is to illustrate how and why cognitive event-related potentials (ERPs)
may help, across various psychopathological populations, to specify the neuro-cognitive alterations
presented by each patient in order to adapt the treatment. With this in mind, different authors
will describe how ERPs may be helpful to better understand the pathophysiological mechanisms
involved in diverse mental diseases and to adapt the therapeutic proposals accordingly. In this
view, discriminating early and late ERPs modifications is thought to be of the greatest relevance
in child psychopathology (Chronaki). A major focus on ERP correlates of attentional control is
presented as a crucial aspect in child social anxiety (Wauthia and Rossignol). It is also suggested
to include self-referential negative contexts when studying ERP correlates of adult social anxiety
(Wieser and Moscovitch), while Cao et al. proposed a major focus on social feedback processes.
Combining cognitive training and neuromodulation is also thought to have a positive impact on
ruminations in major depression by increasing ERPs subtending inhibitory processes (Monnart
et al.). Electroencephalogram (EEG) is also presented as a useful tool to predict outcome treatment
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in obsessive-compulsive disorders (Krause et al.). Moreover,
Brion et al. suggested that ERPs may help to differentiate the
successive steps, envisaged as a continuum, leading patients from
an addictive state (alcohol-dependence) to Korsakoff syndrome.
Finally, combining ERPs with hemodynamic data may help
to better tag to pathological emotional disturbances indexing
schizophrenia (Balconi et al.).
Overall, the rationale of this approach is that a better
understanding of the underlying brain neurophysiological
activities, by means of ERPs which are a quite cheap and
easy to implement tool, could be highly useful to clinicians
to install a best suited individualized treatment (specifically
addressing the individual deficits of the patient). Two other
papers finally propose to go one step further by presenting new
“perspective” tools offering innovative possibilities to further
extend the understanding of the electrophysiological correlates
of psychopathological states. First, Karch et al. shed light on the
measurement of neural oscillations to enlight the understanding
of intentional actions. Second Schröder et al. suggest that the
“bimodal” P300 component could offer an interesting add-on
tool in a near future to enhance our understanding of the
pathophysiology subtending mental diseases. We thus hope that
this research topic will simultaneously illustrate: (1) what can
already be done, i.e., the direct potential outcomes that can be
expected right now from developing the use of electrophysiology
in clinical psychopathology; (2) what will soon be possible,
particularly following the development of new methodological
and experimental proposals which will offer new perspectives for
clinicians.
AUTHOR CONTRIBUTIONS
All authors listed have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
REFERENCES
Boothby, L. A., and Doering, P. L. (2005). Acamprosate for the treatment of alcohol
dependence. Clin. Ther. 27, 695–714. doi: 10.1016/j.clinthera.2005.06.015
Campanella, S. (2016). Neurocognitive rehabilitation for addiction medicine: from
neurophysiological markers to cognitive rehabilitation and relapse prevention.
Prog. Brain Res. 224, 85–103. doi: 10.1016/bs.pbr.2015.07.014
Levit Binnun, N., and Golland, Y. (2012). Finding behavioral and network
indicators of brain vulnerability. Front. Hum. Neurosci. 6:10. doi:
10.3389/fnhum.2012.00010
Menon, V. (2011). Large-scale brain networks and psychopathology: a
unifying triple network model. Trends Cogn. Sci. 15, 483–506. doi:
10.1016/j.tics.2011.08.003
Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Martindale,
B., et al. (2002). Psychological treatments in schizophrenia:
II. Meta-analyses of randomized controlled trials of social
skills training and cognitive remediation. Psychol. Med. 32,
783–791.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Campanella and Maurage. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Psychology | www.frontiersin.org 2 November 2016 | Volume 7 | Article 1738
